<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35933467</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Integrative Profiling of Amyotrophic Lateral Sclerosis Lymphoblasts Identifies Unique Metabolic and Mitochondrial Disease Fingerprints.</ArticleTitle><Pagination><StartPage>6373</StartPage><EndPage>6396</EndPage><MedlinePgn>6373-6396</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-022-02980-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with a rapid progression and no effective treatment. Metabolic and mitochondrial alterations in peripheral tissues of ALS patients may present diagnostic and therapeutic interest. We aimed to identify mitochondrial fingerprints in lymphoblast from ALS patients harboring SOD1 mutations (mutSOD1) or with unidentified mutations (undSOD1), compared with age-/sex-matched controls. Three groups of lymphoblasts, from mutSOD1 or undSOD1 ALS patients and age-/sex-matched controls, were obtained from Coriell Biobank and divided into 3 age-/sex-matched cohorts. Mitochondria-associated metabolic pathways were analyzed using Seahorse MitoStress and ATP Rate assays, complemented with metabolic phenotype microarrays, metabolite levels, gene expression, and protein expression and activity. Pooled (all cohorts) and paired (intra-cohort) analyses were performed by using bioinformatic tools, and the features with higher information gain values were selected and used for principal component analysis and Na&#xef;ve Bayes classification. Considering the group as a target, the features that contributed to better segregation of control, undSOD1, and mutSOD1 were found to be the protein levels of Tfam and glycolytic ATP production rate. Metabolic phenotypic profiles in lymphoblasts from ALS patients with mutSOD1 and undSOD1 revealed unique age-dependent different substrate oxidation profiles. For most parameters, different patterns of variation in experimental endpoints in lymphoblasts were found between cohorts, which may be due to the age or sex of the donor. In the present work, we investigated several metabolic and mitochondrial hallmarks in lymphoblasts from each donor, and although a high heterogeneity of results was found, we identified specific metabolic and mitochondrial fingerprints, especially protein levels of Tfam and glycolytic ATP production rate, that may have a diagnostic and therapeutic interest.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cunha-Oliveira</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-7382-0339</Identifier><AffiliationInfo><Affiliation>CNC-Center for Neuroscience and Cell Biology, CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal. teresa.oliveira@cnc.uc.pt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CNC-Center for Neuroscience and Cell Biology, CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sard&#xe3;o</LastName><ForeName>Vilma</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>CNC-Center for Neuroscience and Cell Biology, CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreiro</LastName><ForeName>Elisabete</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>CNC-Center for Neuroscience and Cell Biology, CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mena</LastName><ForeName>D&#xe9;bora</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CNC-Center for Neuroscience and Cell Biology, CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Francisco B</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>CISUC-Center for Informatics &amp; Systems, University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Polytechnic Institute of Coimbra, Coimbra Institute of Engineering, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borges</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Paulo J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>CNC-Center for Neuroscience and Cell Biology, CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Filomena S G</ForeName><Initials>FSG</Initials><AffiliationInfo><Affiliation>CNC-Center for Neuroscience and Cell Biology, CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal. filomenasilva@mitotag.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mitotag Lda, Biocant Park, Cantanhede, Portugal. filomenasilva@mitotag.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028361" MajorTopicYN="Y">Mitochondrial Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Bioenergetics</Keyword><Keyword MajorTopicYN="N">Cellular metabolism</Keyword><Keyword MajorTopicYN="N">Mitochondria</Keyword><Keyword MajorTopicYN="N">Superoxide dismutase 1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>6</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35933467</ArticleId><ArticleId IdType="doi">10.1007/s12035-022-02980-7</ArticleId><ArticleId IdType="pii">10.1007/s12035-022-02980-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Longinetti E, Fang F (2019) Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol 32(5):771&#x2013;776. https://doi.org/10.1097/WCO.0000000000000730</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId><ArticleId IdType="pmc">6735526</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhasmana S, Dhasmana A, Narula AS, Jaggi M, Yallapu MM, Chauhan SC (2021) The panoramic view of amyotrophic lateral sclerosis: a fatal intricate neurological disorder. Life Sci 288:120156. https://doi.org/10.1016/j.lfs.2021.120156</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.120156</ArticleId><ArticleId IdType="pubmed">34801512</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian TH, Boddy S, Islam M, Kurz J, Whittaker KJ, Moll T, Harvey C, Zhang S et al (2021) A review of Mendelian randomization in amyotrophic lateral sclerosis. Brain. https://doi.org/10.1093/brain/awab420</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Leigh PN (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4:3. https://doi.org/10.1186/1750-1172-4-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId><ArticleId IdType="pmc">2656493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D et al (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int 6:171. https://doi.org/10.4103/2152-7806.169561</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId><ArticleId IdType="pmc">4653353</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews JA, Jackson CE, Heiman-Patterson TD, Bettica P, Brooks BR, Pioro EP (2020) Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 21(7&#x2013;8):509&#x2013;518. https://doi.org/10.1080/21678421.2020.1771734</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1771734</ArticleId><ArticleId IdType="pubmed">32573277</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M, Sakata T, Palumbo J, Akimoto M (2016) A 24-week, phase III, double-blind, parallel-group study of edaravone (MCI-186) for treatment of amyotrophic lateral sclerosis (ALS)(P3. 189). AAN Enterprises</Citation></Reference><Reference><Citation>Group WGOBOTEAS (2017) Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 16(7):505&#x2013;512. https://doi.org/10.1016/S1474-4422(17)30115-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, De Vos KJ (2019) The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett 710:132933. https://doi.org/10.1016/j.neulet.2017.06.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdmanis PN, Rouleau GA (2008) Genetics of familial amyotrophic lateral sclerosis. Neurology 70(2):144&#x2013;152. https://doi.org/10.1212/01.wnl.0000296811.19811.db</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000296811.19811.db</ArticleId><ArticleId IdType="pubmed">18180444</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacman SR, Bradley WG, Moraes CT (2006) Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target? Mol Neurobiol 33(2):113&#x2013;131. https://doi.org/10.1385/MN:33:2:113</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/MN:33:2:113</ArticleId><ArticleId IdType="pubmed">16603792</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo GM, Manfredi G (2015) Exploring new pathways of neurodegeneration in ALS: the role of mitochondria quality control. Brain Res 1607:36&#x2013;46. https://doi.org/10.1016/j.brainres.2014.09.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.09.065</ArticleId><ArticleId IdType="pubmed">25301687</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M, Carri MT (2012) Mitochondrial dysfunction in ALS. Prog Neurobiol 97(2):54&#x2013;66. https://doi.org/10.1016/j.pneurobio.2011.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.06.003</ArticleId><ArticleId IdType="pubmed">21827820</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel SH, Beers DR, Zhao W (2021) Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration. Curr Opin Neurol 34(5):765&#x2013;772. https://doi.org/10.1097/WCO.0000000000000983</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000983</ArticleId><ArticleId IdType="pubmed">34402459</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, Kunz WS (1998) Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 156(1):65&#x2013;72. https://doi.org/10.1016/s0022-510x(98)00008-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(98)00008-2</ArticleId><ArticleId IdType="pubmed">9559989</ArticleId></ArticleIdList></Reference><Reference><Citation>Vielhaber S, Winkler K, Kirches E, Kunz D, Buchner M, Feistner H, Elger CE, Ludolph AC et al (1999) Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci 169(1&#x2013;2):133&#x2013;139. https://doi.org/10.1016/s0022-510x(99)00236-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00236-1</ArticleId><ArticleId IdType="pubmed">10540022</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y, Hirayama K, Terao K (1987) Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Arch Neurol 44(1):103&#x2013;106. https://doi.org/10.1001/archneur.1987.00520130079022</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1987.00520130079022</ArticleId><ArticleId IdType="pubmed">3800708</ArticleId></ArticleIdList></Reference><Reference><Citation>Curti D, Malaspina A, Facchetti G, Camana C, Mazzini L, Tosca P, Zerbi F, Ceroni M (1996) Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology 47(4):1060&#x2013;1064. https://doi.org/10.1212/wnl.47.4.1060</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.47.4.1060</ArticleId><ArticleId IdType="pubmed">8857745</ArticleId></ArticleIdList></Reference><Reference><Citation>Golpich M, Amini E, Mohamed Z, Azman Ali R, Mohamed Ibrahim N, Ahmadiani A (2017) Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment. CNS Neurosci Ther 23(1):5&#x2013;22. https://doi.org/10.1111/cns.12655</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12655</ArticleId><ArticleId IdType="pubmed">27873462</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K (2015) Familial amyotrophic lateral sclerosis. Neurol Clin 33(4):807&#x2013;830. https://doi.org/10.1016/j.ncl.2015.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId><ArticleId IdType="pmc">4670044</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, Getzoff ED, Hu P, Herzfeldt B et al (1993) Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261(5124):1047&#x2013;1051. https://doi.org/10.1126/science.8351519</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SJ, McKeown SR, Rashid S (2016) Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene 577(2):109&#x2013;118. https://doi.org/10.1016/j.gene.2015.11.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59&#x2013;62. https://doi.org/10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Synofzik M, Ronchi D, Keskin I, Basak AN, Wilhelm C, Gobbi C, Birve A, Biskup S et al (2012) Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS. Hum Mol Genet 21(16):3568&#x2013;3574. https://doi.org/10.1093/hmg/dds188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds188</ArticleId><ArticleId IdType="pubmed">22595972</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller K, Oh KW, Nordin A, Panthi S, Kim SH, Nordin F, Freischmidt A, Ludolph AC et al (2022) De novo mutations in SOD1 are a cause of ALS. J Neurol Neurosurg Psychiatry 93(2):201&#x2013;206. https://doi.org/10.1136/jnnp-2021-327520</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327520</ArticleId><ArticleId IdType="pubmed">34518333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M, D&#x2019;Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, Manfredi G (2002) Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem 277(33):29626&#x2013;29633. https://doi.org/10.1074/jbc.M203065200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne SE, Bowling AC, Baik MJ, Gurney M, Brown RH Jr, Beal MF (1998) Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. J Neurochem 71(1):281&#x2013;287. https://doi.org/10.1046/j.1471-4159.1998.71010281.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.71010281.x</ArticleId><ArticleId IdType="pubmed">9648876</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung C, Higgins CM, Xu Z (2002) Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J Neurochem 83(3):535&#x2013;545. https://doi.org/10.1046/j.1471-4159.2002.01112.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01112.x</ArticleId><ArticleId IdType="pubmed">12390515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkinezos IG, Bacman SR, Hernandez D, Oca-Cossio J, Arias LJ, Perez-Pinzon MA, Bradley WG, Moraes CT (2005) Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J Neurosci 25(1):164&#x2013;172. https://doi.org/10.1523/JNEUROSCI.3829-04.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3829-04.2005</ArticleId><ArticleId IdType="pubmed">15634778</ArticleId><ArticleId IdType="pmc">6725219</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies FM, Cookson MR, Taylor RW, Turnbull DM, Chrzanowska-Lightowlers ZM, Dong L, Figlewicz DA, Shaw PJ (2002) Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 125(Pt 7):1522&#x2013;1533. https://doi.org/10.1093/brain/awf167</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awf167</ArticleId><ArticleId IdType="pubmed">12077002</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabria E, Scambi I, Bonafede R, Schiaffino L, Peroni D, Potrich V, Capelli C, Schena F et al (2019) ASCs-exosomes recover coupling efficiency and mitochondrial membrane potential in an in vitro model of ALS. Front Neurosci 13:1070. https://doi.org/10.3389/fnins.2019.01070</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01070</ArticleId><ArticleId IdType="pubmed">31680811</ArticleId><ArticleId IdType="pmc">6811497</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowling AC, Schulz JB, Brown RH Jr, Beal MF (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61(6):2322&#x2013;2325. https://doi.org/10.1111/j.1471-4159.1993.tb07478.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1993.tb07478.x</ArticleId><ArticleId IdType="pubmed">8245985</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D, Rognoni F, van Duijn W, Verspaget HW, Haasdijk ED, Holstege JC (2001) CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol 102(4):293&#x2013;305. https://doi.org/10.1007/s004010100399</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010100399</ArticleId><ArticleId IdType="pubmed">11603803</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins CM, Jung C, Ding H, Xu Z (2002) Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J Neurosci 22(6):RC215. https://doi.org/10.1523/JNEUROSCI.22-06-j0001.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-06-j0001.2002</ArticleId><ArticleId IdType="pubmed">11886899</ArticleId><ArticleId IdType="pmc">6758252</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lillo C, Jonsson PA, Vande Velde C, Ward CM, Miller TM, Subramaniam JR, Rothstein JD et al (2004) Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43(1):5&#x2013;17. https://doi.org/10.1016/j.neuron.2004.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergemalm D, Jonsson PA, Graffmo KS, Andersen PM, Brannstrom T, Rehnmark A, Marklund SL (2006) Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models. J Neurosci 26(16):4147&#x2013;4154. https://doi.org/10.1523/JNEUROSCI.5461-05.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5461-05.2006</ArticleId><ArticleId IdType="pubmed">16624935</ArticleId><ArticleId IdType="pmc">6673995</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Shi Y, Furukawa Y, Zhai H, Fu R, Liu E, Gorrie GH, Khan MS et al (2006) Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci U S A 103(18):7142&#x2013;7147. https://doi.org/10.1073/pnas.0602046103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602046103</ArticleId><ArticleId IdType="pubmed">16636275</ArticleId><ArticleId IdType="pmc">1447523</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C, Miller TM, Cashman NR, Cleveland DW (2008) Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci U S A 105(10):4022&#x2013;4027. https://doi.org/10.1073/pnas.0712209105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712209105</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId><ArticleId IdType="pmc">2268797</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, Brown RH Jr (2004) Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43(1):19&#x2013;30. https://doi.org/10.1016/j.neuron.2004.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan-Barmatz V, Cleveland DW (2010) Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 67(4):575&#x2013;587. https://doi.org/10.1016/j.neuron.2010.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId><ArticleId IdType="pmc">2941987</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayvergiya C, Beal MF, Buck J, Manfredi G (2005) Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J Neurosci 25(10):2463&#x2013;2470. https://doi.org/10.1523/JNEUROSCI.4385-04.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4385-04.2005</ArticleId><ArticleId IdType="pubmed">15758154</ArticleId><ArticleId IdType="pmc">6725162</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand MD (2000) Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp Gerontol 35(6&#x2013;7):811&#x2013;820. https://doi.org/10.1016/s0531-5565(00)00135-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0531-5565(00)00135-2</ArticleId><ArticleId IdType="pubmed">11053672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA (2002) Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem 80(4):616&#x2013;625. https://doi.org/10.1046/j.0022-3042.2001.00731.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber NS, Shepheard SR, Sassani M, McDonough HE, Moore SA, Alix JJP, Wilkinson ID, Jenkins TM, Shaw PJ (2019) Biomarkers in motor neuron disease: a state of the art review. Front Neurol 10:291. https://doi.org/10.3389/fneur.2019.00291</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00291</ArticleId><ArticleId IdType="pubmed">31001186</ArticleId><ArticleId IdType="pmc">6456669</ArticleId></ArticleIdList></Reference><Reference><Citation>Vielhaber S, Kunz D, Winkler K, Wiedemann FR, Kirches E, Feistner H, Heinze HJ, Elger CE et al (2000) Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 123(Pt 7):1339&#x2013;1348. https://doi.org/10.1093/brain/123.7.1339</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/123.7.1339</ArticleId><ArticleId IdType="pubmed">10869047</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghiasi P, Hosseinkhani S, Noori A, Nafissi S, Khajeh K (2012) Mitochondrial complex I deficiency and ATP/ADP ratio in lymphocytes of amyotrophic lateral sclerosis patients. Neurol Res 34(3):297&#x2013;303. https://doi.org/10.1179/1743132812Y.0000000012</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1743132812Y.0000000012</ArticleId><ArticleId IdType="pubmed">22450425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk K, Gennings C, Hupf JC, Tadesse S, D&#x2019;Aurelio M, Kawamata H, Valsecchi F, Mitsumoto H et al (2014) Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients. Ann Neurol 76(4):620&#x2013;624. https://doi.org/10.1002/ana.24244</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24244</ArticleId><ArticleId IdType="pubmed">25090982</ArticleId><ArticleId IdType="pmc">4192005</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM et al (2017) Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Mol Neurodegener 12(1):76. https://doi.org/10.1186/s13024-017-0217-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0217-5</ArticleId><ArticleId IdType="pubmed">29065921</ArticleId><ArticleId IdType="pmc">5655870</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Vande Velde C, Israelson A, Xie J, Bailey AO, Dong MQ, Chun SJ, Roy T et al (2010) ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci U S A 107(49):21146&#x2013;21151. https://doi.org/10.1073/pnas.1014862107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014862107</ArticleId><ArticleId IdType="pubmed">21078990</ArticleId><ArticleId IdType="pmc">3000256</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha-Oliveira T, Silva DF, Segura L, Baldeiras I, Marques R, Rosenstock T, Oliveira PJ, Silva FSG (2022) Redox profiles of amyotrophic lateral sclerosis lymphoblasts with or without known SOD1 mutations. Eur J Clin Invest e13798. https://doi.org/10.1111/eci.13798</Citation></Reference><Reference><Citation>Lei XH, Bochner BR (2021) Optimization of cell permeabilization in electron flow based mitochondrial function assays. Free Radic Biol Med 177:48&#x2013;57. https://doi.org/10.1016/j.freeradbiomed.2021.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.10.014</ArticleId><ArticleId IdType="pubmed">34656699</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry SW, Norman JP, Barbieri J, Brown EB, Gelbard HA (2011) Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 50(2):98&#x2013;115. https://doi.org/10.2144/000113610</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/000113610</ArticleId><ArticleId IdType="pubmed">21486251</ArticleId><ArticleId IdType="pmc">3115691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248&#x2013;254. https://doi.org/10.1006/abio.1976.9999</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abio.1976.9999</ArticleId><ArticleId IdType="pubmed">942051</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Calvo I, Ocon B, Martinez-Moya P, Suarez MD, Zarzuelo A, Martinez-Augustin O, de Medina FS (2010) Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401(2):318&#x2013;320. https://doi.org/10.1016/j.ab.2010.02.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2010.02.036</ArticleId><ArticleId IdType="pubmed">20206115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mire-Sluis AR, Page L, Thorpe R (1995) Quantitative cell line based bioassays for human cytokines. J Immunol Methods 187(2):191&#x2013;199. https://doi.org/10.1016/0022-1759(95)00220-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(95)00220-1</ArticleId><ArticleId IdType="pubmed">7499878</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmeyer HU, Bernt E (1974) UV-assay with pyruvate and NADH. In: Methods of enzymatic analysis. pp 574&#x2013;579. https://doi.org/10.1016/b978-0-12-091302-2.50010-4</Citation></Reference><Reference><Citation>Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76&#x2013;85. https://doi.org/10.1016/0003-2697(85)90442-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(85)90442-7</ArticleId><ArticleId IdType="pubmed">3843705</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmeyer HU, Grassl M, H W (1983) Hexokinase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, vol 3 (II). Verlag Chemie, Weinheim, pp 222&#x2013;223</Citation></Reference><Reference><Citation>Dem&#x161;ar J, Curk T, Erjavec A, Gorup &#x10c;, Ho&#x10d;evar T, Milutinovi&#x10d; M, Mo&#x17e;ina M, Polajnar M et al (2013) Orange: data mining toolbox in Python. J Mach Learn Res 14(1):2349&#x2013;2353</Citation></Reference><Reference><Citation>Szelechowski M, Amoedo N, Obre E, Leger C, Allard L, Bonneu M, Claverol S, Lacombe D et al (2018) Metabolic reprogramming in amyotrophic lateral sclerosis. Sci Rep 8(1):3953. https://doi.org/10.1038/s41598-018-22318-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22318-5</ArticleId><ArticleId IdType="pubmed">29500423</ArticleId><ArticleId IdType="pmc">5834494</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak J, Debska-Vielhaber G, Vielhaber S, Szymanski J, Charzynska A, Duszynski J, Szczepanowska J (2019) Distinction of sporadic and familial forms of ALS based on mitochondrial characteristics. FASEB J 33(3):4388&#x2013;4403. https://doi.org/10.1096/fj.201801843R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201801843R</ArticleId><ArticleId IdType="pubmed">30550341</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Rajan S, Duffy L, Mortiboys H, Higginbottom A, Grierson AJ, Shaw PJ (2014) Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiol Aging 35(6):1499&#x2013;1509. https://doi.org/10.1016/j.neurobiolaging.2013.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.11.025</ArticleId><ArticleId IdType="pubmed">24439480</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R, Allen SP, Goodall EF, Kramer S, Ponger LL, Heath PR, Milo M, Hollinger HC et al (2015) Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathol Appl Neurobiol 41(2):201&#x2013;226. https://doi.org/10.1111/nan.12147</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12147</ArticleId><ArticleId IdType="pubmed">24750211</ArticleId><ArticleId IdType="pmc">4329387</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerou M, Hall B, Woof R, Allsop J, Kolb SJ, Meyer K, Shaw PJ, Allen SP (2021) Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts. Neurobiol Aging 105:64&#x2013;77. https://doi.org/10.1016/j.neurobiolaging.2021.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.04.013</ArticleId><ArticleId IdType="pubmed">34044197</ArticleId><ArticleId IdType="pmc">8346650</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A, Zoll J, Ribera F, Tranchant C, Warter JM, Lonsdorfer J, Lampert E (2002) Mitochondrial respiratory chain function in skeletal muscle of ALS patients. Ann Neurol 52(5):623&#x2013;627. https://doi.org/10.1002/ana.10357</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10357</ArticleId><ArticleId IdType="pubmed">12402260</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo BG, Souza ESLF, de Barros Torresi JL, Siena A, Valerio BCO, Brito MD, Rosenstock TR (2020) Decreased mitochondrial function, biogenesis, and degradation in peripheral blood mononuclear cells from amyotrophic lateral sclerosis patients as a potential tool for biomarker research. Mol Neurobiol 57(12):5084&#x2013;5102. https://doi.org/10.1007/s12035-020-02059-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02059-1</ArticleId><ArticleId IdType="pubmed">32840822</ArticleId><ArticleId IdType="pmc">7541388</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S, Aijo T, Vickovic S, Braine C, Kang K, Mollbrink A, Fagegaltier D, Andrusivova Z et al (2019) Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science 364(6435):89&#x2013;93. https://doi.org/10.1126/science.aav9776</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M, Dion PA, Rouleau GA (2016) ALS: recent developments from genetics studies. Curr Neurol Neurosci Rep 16(6):59. https://doi.org/10.1007/s11910-016-0658-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-016-0658-1</ArticleId><ArticleId IdType="pubmed">27113253</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal NA, Berry JD, Windebank A, Staff NP, Maragakis NJ, van den Berg LH, Genge A, Miller R et al (2020) Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle Nerve 62(2):156&#x2013;166. https://doi.org/10.1002/mus.26801</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26801</ArticleId><ArticleId IdType="pubmed">31899540</ArticleId><ArticleId IdType="pmc">7496557</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz JS, Barohn RJ, Dimachkie MM, Mitsumoto H (2015) The dilemma of the clinical trialist in amyotrophic lateral sclerosis: the hurdles to finding a cure. Neurol Clin 33(4):937&#x2013;947. https://doi.org/10.1016/j.ncl.2015.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.014</ArticleId><ArticleId IdType="pubmed">26515630</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong A, Evstratova A, Sivitilli A, Hernandez JJ, Gosio J, Wahedi A, Sondheimer N, Wrana JL et al (2021) Characterization of mitochondrial health from human peripheral blood mononuclear cells to cerebral organoids derived from induced pluripotent stem cells. Sci Rep 11(1):4523. https://doi.org/10.1038/s41598-021-84071-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84071-6</ArticleId><ArticleId IdType="pubmed">33633238</ArticleId><ArticleId IdType="pmc">7907388</ArticleId></ArticleIdList></Reference><Reference><Citation>Masson JJR, Ostrowski M, Duette G, Lee MKS, Murphy AJ, Crowe SM, Palmer CS (2020) The multiparametric analysis of mitochondrial dynamics in T cells from cryopreserved peripheral blood mononuclear cells (PBMCs). Methods Mol Biol 2184:215&#x2013;224. https://doi.org/10.1007/978-1-0716-0802-9_15</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-0802-9_15</ArticleId><ArticleId IdType="pubmed">32808228</ArticleId></ArticleIdList></Reference><Reference><Citation>Naia L, Ferreira IL, Cunha-Oliveira T, Duarte AI, Ribeiro M, Rosenstock TR, Laco MN, Ribeiro MJ et al (2015) Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington&#x2019;s disease human lymphoblasts. Mol Neurobiol 51(1):331&#x2013;348. https://doi.org/10.1007/s12035-014-8735-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8735-4</ArticleId><ArticleId IdType="pubmed">24841383</ArticleId></ArticleIdList></Reference><Reference><Citation>Panov A, Obertone T, Bennett-Desmelik J, Greenamyre JT (1999) Ca(2+)-dependent permeability transition and complex I activity in lymphoblast mitochondria from normal individuals and patients with Huntington&#x2019;s or Alzheimer&#x2019;s disease. Ann N Y Acad Sci 893:365&#x2013;368. https://doi.org/10.1111/j.1749-6632.1999.tb07856.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1999.tb07856.x</ArticleId><ArticleId IdType="pubmed">10672268</ArticleId></ArticleIdList></Reference><Reference><Citation>Annesley SJ, Lay ST, De Piazza SW, Sanislav O, Hammersley E, Allan CY, Francione LM, Bui MQ et al (2016) Immortalized Parkinson&#x2019;s disease lymphocytes have enhanced mitochondrial respiratory activity. Dis Model Mech 9(11):1295&#x2013;1305. https://doi.org/10.1242/dmm.025684</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.025684</ArticleId><ArticleId IdType="pubmed">27638668</ArticleId><ArticleId IdType="pmc">5117226</ArticleId></ArticleIdList></Reference><Reference><Citation>Guareschi S, Cova E, Cereda C, Ceroni M, Donetti E, Bosco DA, Trotti D, Pasinelli P (2012) An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc Natl Acad Sci U S A 109(13):5074&#x2013;5079. https://doi.org/10.1073/pnas.1115402109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115402109</ArticleId><ArticleId IdType="pubmed">22416121</ArticleId><ArticleId IdType="pmc">3324021</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson CM, Falkenberg M, Larsson NG (2016) Maintenance and expression of mammalian mitochondrial DNA. Annu Rev Biochem 85:133&#x2013;160. https://doi.org/10.1146/annurev-biochem-060815-014402</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060815-014402</ArticleId><ArticleId IdType="pubmed">27023847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang I, Chu CT, Kaufman BA (2018) The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms. FEBS Lett 592(5):793&#x2013;811. https://doi.org/10.1002/1873-3468.12989</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12989</ArticleId><ArticleId IdType="pubmed">29364506</ArticleId><ArticleId IdType="pmc">5851836</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeney PM, Bennett JP Jr (2010) ALS spinal neurons show varied and reduced mtDNA gene copy numbers and increased mtDNA gene deletions. Mol Neurodegener 5:21. https://doi.org/10.1186/1750-1326-5-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-5-21</ArticleId><ArticleId IdType="pubmed">20504367</ArticleId><ArticleId IdType="pmc">2889994</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto N, Miyazaki K, Kurata T, Ikeda Y, Matsuura T, Kang D, Ide T, Abe K (2012) Effect of mitochondrial transcription factor a overexpression on motor neurons in amyotrophic lateral sclerosis model mice. J Neurosci Res 90(6):1200&#x2013;1208. https://doi.org/10.1002/jnr.23000</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23000</ArticleId><ArticleId IdType="pubmed">22354563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A, Coccurello R (2017) What is &#x201c;Hyper&#x201d; in the ALS hypermetabolism? Mediators Inflamm 2017:7821672. https://doi.org/10.1155/2017/7821672</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7821672</ArticleId><ArticleId IdType="pubmed">29081604</ArticleId><ArticleId IdType="pmc">5610793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256(8):1236&#x2013;1242. https://doi.org/10.1007/s00415-009-5100-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A, Heshmat S, Henders AK et al (2018) Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry 89(10):1016&#x2013;1023. https://doi.org/10.1136/jnnp-2017-317887</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, Bordoni M, Diamanti L, Sproviero D, Gagliardi S, Cereda C (2018) SOD1 in amyotrophic lateral sclerosis: &#x201c;Ambivalent&#x201d; behavior connected to the disease. Int J Mol Sci 19(5). https://doi.org/10.3390/ijms19051345</Citation></Reference><Reference><Citation>Huai J, Zhang Z (2019) Structural properties and interaction partners of familial ALS-associated SOD1 mutants. Front Neurol 10:527. https://doi.org/10.3389/fneur.2019.00527</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00527</ArticleId><ArticleId IdType="pubmed">31164862</ArticleId><ArticleId IdType="pmc">6536575</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara Y, Nobukuni K, Takata H, Hayabara T (2005) Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation. Neurol Res 27(1):105&#x2013;108. https://doi.org/10.1179/016164105X18430</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164105X18430</ArticleId><ArticleId IdType="pubmed">15829169</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim MB, Kang JH, Yim HS, Kwak HS, Chock PB, Stadtman ER (1996) A gain-of-function of an amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc Natl Acad Sci U S A 93(12):5709&#x2013;5714. https://doi.org/10.1073/pnas.93.12.5709</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.12.5709</ArticleId><ArticleId IdType="pubmed">8650157</ArticleId><ArticleId IdType="pmc">39125</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RH Jr, Price DL et al (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci U S A 91(17):8292&#x2013;8296. https://doi.org/10.1073/pnas.91.17.8292</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.17.8292</ArticleId><ArticleId IdType="pubmed">8058797</ArticleId><ArticleId IdType="pmc">44592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokic AN, Stevic Z, Stojanovic S, Blagojevic DP, Jones DR, Pavlovic S, Niketic V, Apostolski S et al (2005) Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Redox Rep 10(5):265&#x2013;270. https://doi.org/10.1179/135100005X70242</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/135100005X70242</ArticleId><ArticleId IdType="pubmed">16354415</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharaoh G, Sataranatarajan K, Street K, Hill S, Gregston J, Ahn B, Kinter C, Kinter M et al (2019) Metabolic and stress response changes precede disease onset in the spinal cord of mutant SOD1 ALS mice. Front Neurosci 13:487. https://doi.org/10.3389/fnins.2019.00487</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00487</ArticleId><ArticleId IdType="pubmed">31213966</ArticleId><ArticleId IdType="pmc">6554287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei YH, Wu SB, Ma YS, Lee HC (2009) Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging. Chang Gung Med J 32(2):113&#x2013;132</Citation><ArticleIdList><ArticleId IdType="pubmed">19403001</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Duffy LM, Shaw PJ, Grierson AJ (2015) Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging 36(10):2893&#x2013;2903. https://doi.org/10.1016/j.neurobiolaging.2015.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.07.013</ArticleId><ArticleId IdType="pubmed">26344876</ArticleId></ArticleIdList></Reference><Reference><Citation>Silaidos C, Pilatus U, Grewal R, Matura S, Lienerth B, Pantel J, Eckert GP (2018) Sex-associated differences in mitochondrial function in human peripheral blood mononuclear cells (PBMCs) and brain. Biol Sex Differ 9(1):34. https://doi.org/10.1186/s13293-018-0193-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-018-0193-7</ArticleId><ArticleId IdType="pubmed">30045765</ArticleId><ArticleId IdType="pmc">6060503</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alessandro A, Fu X, Kanias T, Reisz JA, Culp-Hill R, Guo Y, Gladwin MT, Page G et al (2021) Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity. Haematologica 106(5):1290&#x2013;1302. https://doi.org/10.3324/haematol.2020.246603</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2020.246603</ArticleId><ArticleId IdType="pubmed">32241843</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>